StockMarketWire.com - RNA therapeutics developer Silence Therapeutics said chief financial officer Rob Quinn would present at a key conference in Boston.
Quinn would present at the at the Cowen Annual Health Care Conference on 2 March.
At 9:19am: [LON:SLN] Silence Therapeutics PLC share price was -1p at 407p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.